683 Capital Management, LLC - FENNEC PHARMACEUTICALS INC ownership

FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 30 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
683 Capital Management, LLC ownership history of FENNEC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,253,000
-14.9%
300,0000.0%0.18%
-7.9%
Q2 2023$2,649,000
+6.1%
300,0000.0%0.19%
+2.2%
Q1 2023$2,496,000
-13.3%
300,0000.0%0.19%
-23.8%
Q4 2022$2,880,000
-7.6%
300,000
-22.0%
0.24%
+1.2%
Q3 2022$3,117,000
+31.4%
384,824
-9.5%
0.24%
+43.5%
Q2 2022$2,373,000
-12.5%
425,338
-12.2%
0.17%
+15.9%
Q1 2022$2,712,000
-13.1%
484,318
-31.7%
0.14%
+26.1%
Q4 2021$3,121,000
-70.2%
709,300
-36.1%
0.12%
-71.8%
Q3 2021$10,456,000
+29.2%
1,110,0000.0%0.41%
+45.7%
Q2 2021$8,091,000
+17.4%
1,110,0000.0%0.28%
-23.3%
Q1 2021$6,894,000
-16.6%
1,110,0000.0%0.36%
-6.6%
Q4 2020$8,269,000
+22.9%
1,110,0000.0%0.39%
-20.7%
Q3 2020$6,727,000
-27.4%
1,110,0000.0%0.49%
-33.6%
Q2 2020$9,269,000
-17.9%
1,110,000
-41.6%
0.74%
+11.7%
Q1 2020$11,288,000
+83.1%
1,900,000
+100.0%
0.66%
-5.8%
Q4 2019$6,165,000
+32.0%
950,000
-2.2%
0.70%
+35.8%
Q3 2019$4,672,000
+20.3%
971,3510.0%0.52%
+47.0%
Q2 2019$3,885,000
-17.5%
971,3510.0%0.35%
-17.3%
Q1 2019$4,711,000
-24.0%
971,3510.0%0.43%
+13.6%
Q4 2018$6,197,000
-22.2%
971,3510.0%0.38%
-27.3%
Q3 2018$7,965,000
-12.0%
971,351
+12.0%
0.52%
-15.5%
Q2 2018$9,053,000
-13.7%
867,1850.0%0.61%
-34.0%
Q1 2018$10,489,000
+20.7%
867,1850.0%0.93%
+26.6%
Q4 2017$8,689,000
-2.0%
867,185
+7.3%
0.73%
-21.5%
Q3 2017$8,867,000808,3650.93%
Other shareholders
FENNEC PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sonic GP LLC 2,407,357$18,079,25117.55%
Solas Capital Management, LLC 1,725,567$12,959,0089.07%
DG Capital Management, LLC 1,143,099$8,584,6734.70%
HARBERT FUND ADVISORS, INC. 466,869$3,506,1862.56%
AIGH Capital Management LLC 373,526$2,805,1801.33%
Southpoint Capital Advisors LP 4,077,214$30,619,8770.68%
APIS CAPITAL ADVISORS, LLC 70,000$525,7000.68%
Worth Venture Partners, LLC 92,636$695,6960.41%
Lion Point Capital, LP 110,000$826,1000.37%
683 Capital Management, LLC 300,000$2,253,0000.18%
View complete list of FENNEC PHARMACEUTICALS INC shareholders